DR. REYNALDO F. MULINGTAPANG, M.D.

TAMPA, FL

Research Active
Internal Medicine - Interventional Cardiology NPI registered 21+ years 3 publications 1996 – 2008 NPI: 1033114509
Embolization, TherapeuticCoronary AngiographyCholesterolCholesterol, LDLEchocardiographyElectrocardiographyCholesterol, HDLAbnormalities, MultipleHeart SeptumCoronary DiseaseTriglyceridesPhospholipidsHeart Septal Defects, AtrialForamen Ovale, PatentCholesterol, VLDL

Practice Location

4210 W LINEBAUGH AVE
TAMPA, FL 33624-5241

Phone: (813) 884-0923

What does REYNALDO MULINGTAPANG research?

Dr. Mulingtapang studies methods for treating heart conditions, particularly those involving defects in the heart's structure and complications from heart surgeries. He has researched the closure of multiple atrial septal defects—holes in the heart that can lead to serious health issues—using specialized devices to improve patient health. Additionally, he investigates the relationship between fats in the blood and coronary artery disease severity, providing insights that could enhance how doctors assess and treat patients at risk for heart disease. His work includes new strategies for dealing with complications that arise during heart procedures, ensuring safer outcomes for patients.

Key findings

  • In a study on atrial septal defects, procedures were largely successful in 5 patients, with low complication rates during follow-ups ranging from 3 months to 4 years.
  • In a study with 217 men, it was found that higher levels of high-density lipoprotein phospholipids (HDL-P) were linked to less severe coronary artery disease, highlighting the potential for new assessment methods.
  • In a single case report, a 74-year-old man had a successful closure of a perforated vein graft using a stent and a patch from his own vein, which represents a promising method for managing complications in heart surgery.

Frequently asked questions

Does Dr. Mulingtapang study heart defects?
Yes, he focuses on treating multiple atrial septal defects using specialized devices.
What treatments has Dr. Mulingtapang researched for heart disease?
He has researched methods to close atrial septal defects and techniques to manage complications in heart surgeries.
Is Dr. Mulingtapang's work relevant to patients with coronary artery disease?
Yes, his research explores the link between blood fat levels and the severity of coronary artery disease, which is crucial for assessing treatment options.
What kind of patients would benefit from Dr. Mulingtapang's research?
Patients with heart defects, those undergoing heart surgeries, and individuals at risk for heart disease can benefit from his findings.

Publications in plain English

Approach to percutaneous closure in patients with multiple atrial septal defects.

2008

The Journal of invasive cardiology

Tillman T, Mulingtapang R, Sullebarger JT

Plain English
This study looked at how well doctors can close multiple holes in the heart's wall between the two upper chambers, known as atrial septal defects, using special devices. The researchers reported on five patients who needed two devices each to close their defects and found that the procedures were mostly successful, with low rates of complications over follow-ups that lasted from 3 months to 4 years. This is important because it shows that closing multiple defects can be done safely and effectively, helping improve patients' heart health. Who this helps: Patients with multiple atrial septal defects.

PubMed

Serum levels of high-density lipoprotein phospholipids correlate inversely with severity of angiographically defined coronary artery disease.

2000

Atherosclerosis

Lan Hsia S, Duncan R, Schob AH, Chakko SC, Mulingtapang R +2 more

Plain English
This study looked at how different types of fats in the blood are related to the severity of coronary artery disease in 217 men. It found that those with normal arteries had higher levels of high-density lipoprotein phospholipids (HDL-P) and high-density lipoprotein cholesterol (HDL-C), but as the disease got worse, HDL-P levels went down. Understanding this relationship is important because it could help find new ways to assess and treat heart disease. Who this helps: This benefits patients at risk for heart disease and their doctors.

PubMed

Percutaneous bailout therapy of a perforated vein graft using a stent-autologous vein patch.

1996

Catheterization and cardiovascular diagnosis

Colon PJ, Ramee SR, Mulingtapang R, Pridjian A, Bhatia D +1 more

Plain English
This study looked at a 74-year-old man who had a hole in a blocked vein used in heart surgery. Doctors fixed the hole by using a specific type of stent along with a small piece of his own vein, successfully closing it up. This matters because it shows a new way to address complications during heart procedures, improving outcomes for patients with similar issues. Who this helps: This helps patients undergoing heart procedures and their doctors.

PubMed

Frequent Co-Authors

Tywaun Tillman J Thompson Sullebarger S Lan Hsia R Duncan A H Schob S C Chakko J L He G O Perez P J Colon S R Ramee

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.